Definition of human autoimmunity - autoantibodies versus autoimmune disease

Autoimmunity Reviews

Volumn 9, Issue 5, 2010, Pages

  Lleo, Ana ^a,b   Invernizzi, Pietro ^a,b   Gao, Bin ^d   Podda, Mauro ^b,c   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Autoantibody; Autoantigen; Autoimmune disease; B cell; Tolerance

Indexed keywords

AUTOANTIBODY; LIPID;

ANTIBODY DETECTION; ANTIGEN BINDING; APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOLOGICAL TOLERANCE; INFECTION; INFLAMMATION; NEOPLASM; PARANEOPLASTIC SYNDROME; PLACENTAL TRANSFER; REVIEW; TISSUE INJURY;

ANIMALS; ANTIBODIES; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; HUMANS; IMMUNE TOLERANCE; INFLAMMATION; NEOPLASMS; PROTEINS;

EID: 77649239391     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2009.12.002     Document Type: Review

References (60)

1. Selmi C., Mayo M.J., Bach N., Ishibashi H., Invernizzi P., Gish R.G., et al. Primary biliary cirrhosis in monozygotic and dizygotic twins: genetics, epigenetics, and environment. Gastroenterology 127 (2004) 485-492
2. Burek C.L., and Talor M.V. Environmental triggers of autoimmune thyroiditis. J Autoimmun 33 3-4 (2009) 183-189 (Electronic publication ahead of print)
3. Dedeoglu F. Drug-induced autoimmunity. Curr Opin Rheumatol 21 (2009) 547-551
4. Selmi C., and Gershwin M.E. The role of environmental factors in primary biliary cirrhosis. Trends Immunol 30 (2009) 415-420
5. Robbins W.C., Holman H.R., Deicher H., and Kunkel H.G. Complement fixation with cell nuclei and DNA in lupus erythematosus. Proc Soc Exp Biol Med 96 (1957) 575-579
6. Miescher P., and Fauconnet M. Absorption of L. E. factor by isolated cell nuclei. Experientia 10 (1954) 252-253
7. Mackay IR. Travels and travails of autoimmunity: an historical journey from discovery to rediscovery. Autoimmun Rev in press.
8. Mackay I.R. Primary biliary cirrhosis showing a high titer of autoantibody; report of a case. N Engl J Med 258 (1958) 185-188
9. Sauerborn M., and Schellekens H. B-1 cells and naturally occurring antibodies: influencing the immunogenicity of recombinant human therapeutic proteins?. Curr Opin Biotechnol (2009)
10. Kubo T., Uchida Y., Watanabe Y., Abe M., Nakamura A., Ono M., et al. Augmented TLR9-induced Btk activation in PIR-B-deficient B-1 cells provokes excessive autoantibody production and autoimmunity. J Exp Med 206 (2009) 1971-1982
11. Chou M.Y., Fogelstrand L., Hartvigsen K., Hansen L.F., Woelkers D., Shaw P.X., et al. Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. J Clin Invest 119 (2009) 1335-1349
12. Rosen A., and Casciola-Rosen L. Autoantigens in systemic autoimmunity: critical partner in pathogenesis. J Intern Med 265 (2009) 625-631
13. Elluru S.R., Vani J., Delignat S., Bloch M.F., Lacroix-Desmazes S., Kazatchkine M.D., et al. Modulation of human dendritic cell maturation and function by natural IgG antibodies. Autoimmun Rev 7 (2008) 487-490
14. Vani J., Elluru S., Negi V.S., Lacroix-Desmazes S., Kazatchkine M.D., Bayary J., et al. Role of natural antibodies in immune homeostasis: IVIg perspective. Autoimmun Rev 7 (2008) 440-444
15. Durand C.A., Hartvigsen K., Fogelstrand L., Kim S., Iritani S., Vanhaesebroeck B., et al. Phosphoinositide 3-kinase p110delta regulates natural antibody production, marginal zone and B-1 B cell function, and autoantibody responses. J Immunol 183 (2009) 5673-5684
16. Cinamon G., Zachariah M.A., Lam O.M., Foss Jr. F.W., and Cyster J.G. Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat Immunol 9 (2008) 54-62
17. Hedegaard C.J., Chen N., Sellebjerg F., Sorensen P.S., Leslie R.G., Bendtzen K., et al. Autoantibodies to myelin basic protein (MBP) in healthy individuals and in patients with multiple sclerosis: a role in regulating cytokine responses to MBP. Immunology 128 (2009) e451-e461
18. Waldner H. The role of innate immune responses in autoimmune disease development. Autoimmun Rev 8 (2009) 400-404
19. Bei R., Masuelli L., Palumbo C., Modesti M., and Modesti A. A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: Inflammation in their induction and impact on tumor growth. Cancer Lett 281 (2009) 8-23
20. Tan E.M., and Zhang J. Autoantibodies to tumor-associated antigens: reporters from the immune system. Immunol Rev 222 (2008) 328-340
21. Adamus G. Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy. Autoimmun Rev 8 (2009) 410-414
22. Toothaker T.B., and Rubin M. Paraneoplastic neurological syndromes: a review. Neurologist 15 (2009) 21-33
23. Fallarino F., Volpi C., Zelante T., Vacca C., Calvitti M., Fioretti M.C., et al. IDO mediates TLR9-driven protection from experimental autoimmune diabetes. J Immunol 183 (2009) 6303-6312
24. Zanone M.M., Favaro E., Quadri R., Miceli I., Giaretta F., Romagnoli R., et al. Association of cytomegalovirus infections with recurrence of humoral and cellular autoimmunity to islet autoantigens and of type 1 diabetes in a pancreas transplanted patient. Transpl Int (2009)
25. Kivity S., Agmon-Levin N., Blank M., and Shoenfeld Y. Infections and autoimmunity-friends or foes?. Trends Immunol 30 (2009) 409-414
26. Leung P.S., Rossaro L., Davis P.A., Park O., Tanaka A., Kikuchi K., et al. Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis. Hepatology 46 (2007) 1436-1442
27. Anam K., Amare M., Naik S., Szabo K.A., and Davis T.A. Severe tissue trauma triggers the autoimmune state systemic lupus erythematosus in the MRL/++ lupus-prone mouse. Lupus 18 (2009) 318-331
28. Leandro M.J., and de la Torre I. Translational mini-review series on B cell-directed therapies: the pathogenic role of B cells in autoantibody-associated autoimmune diseases-lessons from B cell-depletion therapy. Clin Exp Immunol 157 (2009) 191-197
29. Ohishi K., Kanoh M., Shinomiya H., Hitsumoto Y., and Utsumi S. Complement activation by cross-linked B cell-membrane IgM. J Immunol 154 (1995) 3173-3179
30. Frisoni L., McPhie L., Colonna L., Sriram U., Monestier M., Gallucci S., et al. Nuclear autoantigen translocation and autoantibody opsonization lead to increased dendritic cell phagocytosis and presentation of nuclear antigens: a novel pathogenic pathway for autoimmunity?. J Immunol 175 (2005) 2692-2701
31. Walport M.J. Complement. First of two parts. N Engl J Med 344 (2001) 1058-1066
32. Walport M.J. Complement. Second of two parts. N Engl J Med 344 (2001) 1140-1144
33. Fang C., Zhang X., Miwa T., and Song W.C. Complement promotes the development of inflammatory T-helper 17 cells through synergistic interaction with Toll-like receptor signaling and interleukin-6 production. Blood 114 (2009) 1005-1015
34. Rodien P., Madec A.M., Ruf J., Rajas F., Bornet H., Carayon P., et al. Antibody-dependent cell-mediated cytotoxicity in autoimmune thyroid disease: relationship to antithyroperoxidase antibodies. J Clin Endocrinol Metab 81 (1996) 2595-2600
35. Gehrs B.C., and Friedberg R.C. Autoimmune hemolytic anemia. Am J Hematol 69 (2002) 258-271
36. Keeling D.M., and Isenberg D.A. Haematological manifestations of systemic lupus erythematosus. Blood Rev 7 (1993) 199-207
37. Byrne A., and Reen D.J. Lipopolysaccharide induces rapid production of IL-10 by monocytes in the presence of apoptotic neutrophils. J Immunol 168 (2002) 1968-1977
38. Gaipl U.S., Munoz L.E., Grossmayer G., Lauber K., Franz S., Sarter K., et al. Clearance deficiency and systemic lupus erythematosus (SLE). J Autoimmun 28 (2007) 114-121
39. Lleo A., Selmi C., Invernizzi P., Podda M., and Gershwin M.E. The consequences of apoptosis in autoimmunity. J Autoimmun 31 (2008) 257-262
40. Meagher L.C., Savill J.S., Baker A., Fuller R.W., and Haslett C. Phagocytosis of apoptotic neutrophils does not induce macrophage release of thromboxane B2. J Leukoc Biol 52 (1992) 269-273
41. Clancy R.M., Neufing P.J., Zheng P., O'Mahony M., Nimmerjahn F., Gordon T.P., et al. Impaired clearance of apoptotic cardiocytes is linked to anti-SSA/Ro and -SSB/La antibodies in the pathogenesis of congenital heart block. J Clin Invest 116 (2006) 2413-2422
42. Clancy R.M., Kapur R.P., Molad Y., Askanase A.D., and Buyon J.P. Immunohistologic evidence supports apoptosis, IgG deposition, and novel macrophage/fibroblast crosstalk in the pathologic cascade leading to congenital heart block. Arthritis Rheum 50 (2004) 173-182
43. Dayan C.M., and Daniels G.H. Chronic autoimmune thyroiditis. N Engl J Med 335 (1996) 99-107
44. Meriggioli M.N., and Sanders D.B. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol 8 (2009) 475-490
45. Rapoport B., and McLachlan S.M. Thyroid autoimmunity. J Clin Invest 108 (2001) 1253-1259
46. Ooi J.D., Holdsworth S.R., and Kitching A.R. Advances in the pathogenesis of Goodpasture's disease: from epitopes to autoantibodies to effector T cells. J Autoimmun 31 (2008) 295-300
47. Singh R.R. SLE: translating lessons from model systems to human disease. Trends Immunol 26 (2005) 572-579
48. Kono D.H., Haraldsson M.K., Lawson B.R., Pollard K.M., Koh Y.T., Du X., et al. Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus. Proc Natl Acad Sci U S A 106 (2009) 12061-12066
49. Hansen M.H., Nielsen H.V., and Ditzel H.J. Translocation of an intracellular antigen to the surface of medullary breast cancer cells early in apoptosis allows for an antigen-driven antibody response elicited by tumor-infiltrating B cells. J Immunol 169 (2002) 2701-2711
50. Ravichandran K.S., and Lorenz U. Engulfment of apoptotic cells: signals for a good meal. Nat Rev Immunol 7 (2007) 964-974
51. Fadok V.A., Bratton D.L., Konowal A., Freed P.W., Westcott J.Y., and Henson P.M. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 101 (1998) 890-898
52. Lleo A., Selmi C., Invernizzi P., Podda M., Coppel R.L., Mackay I.R., et al. Apotopes and the biliary specificity of primary biliary cirrhosis. Hepatology 49 (2009) 871-879
53. Alarcon-Segovia D., Ruiz-Arguelles A., and Fishbein E. Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors. Nature 271 (1978) 67-69
54. Matsumura S., Van De Water J., Leung P., Odin J.A., Yamamoto K., Gores G.J., et al. Caspase induction by IgA antimitochondrial antibody: IgA-mediated biliary injury in primary biliary cirrhosis. Hepatology 39 (2004) 1415-1422
55. Pierangeli S.S., Chen P.P., Raschi E., Scurati S., Grossi C., Borghi M.O., et al. Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms. Semin Thromb Hemost 34 (2008) 236-250
56. Salmon J.E., and de Groot P.G. Pathogenic role of antiphospholipid antibodies. Lupus 17 (2008) 405-411
57. Clancy R.M., Backer C.B., Yin X., Chang M.W., Cohen S.R., Lee L.A., et al. Genetic association of cutaneous neonatal lupus with HLA class II and tumor necrosis factor alpha: implications for pathogenesis. Arthritis Rheum 50 (2004) 2598-2603
58. Weller T.H., and Coons A.H. Fluorescent antibody studies with agents of varicella and herpes zoster propagated in vitro. Proc Soc Exp Biol Med 86 (1954) 789-794
59. Oertelt S., Rieger R., Selmi C., Invernizzi P., Ansari A.A., Coppel R.L., et al. A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosis. Hepatology 45 (2007) 659-665
60. Fathman C.G., Soares L., Chan S.M., and Utz P.J. An array of possibilities for the study of autoimmunity. Nature 435 (2005) 605-611